Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A straightforward comparison of the Djia and the S&P 500, focusing on diversification, volatility profiles, and historical performance to guide decision making.
22,615 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Market bifurcation put Meta Platforms and Netflix on opposite growth tracks in early 2026. One path could double asse...
Oil prices rose again as investors weighed a mix of Middle East signals and shifting Iran policy on the Strait of Hor...
The trending meme coin Pippin shed roughly half of its value in 24 hours, triggering a split among traders between fe...
A new ETF focused on global dividend growers aims to deliver steady income and long-term growth. Retirees weigh modes...
DeFi founders argue that tokenized assets are the next growth lever, linking real-world value to on-chain liquidity. ...
Atlantic Avenue Mortgage tops January HECM broker endorsements, signaling strong demand for senior home equity even a...
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
Brent crude climbs to $113.71 per barrel on March 19, 2026, as traders weigh supply discipline and demand signals. He...
Tesla shares slipped as three major developments tug the stock in mixed directions: stricter autonomous driving overs...
New York’s upstart candidate Jack Schlossberg argues JFK would be alarmed by America’s global standing, while acknowl...
Three global e-commerce leaders are trading at bargain prices as reinvestment cycles press on near‑term earnings, pot...